A clinical study of the restored kidney transplantation from living donors with small renal tumors by nephrectomy - A clinical study of the restored kidney transplantation from living donors with small renal tumors by nephrectomy

Tokushukai Medical Group0 sites42 target enrollmentJanuary 24, 2017

Overview

Phase: 未知
Intervention: Not specified
Conditions: For Donor:small renal tumors For Recipient:End stage chronic renal failure
Sponsor: Tokushukai Medical Group
Enrollment: 42
Status: Recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

January 24, 2017

End Date

June 30, 2029

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Tokushukai Medical Group

•For Donor: 1\. Patients who have received anti\-cancer drugs (including molecular targeted drugs, cytokines, etc.) or other drugs within one month of nephrectomy. 2\. Patients with a history of irradiation of the kidney to be removed. 3\. Suspected renal tumours such as malignant lymphoma or sarcoma, or malignant tumours outside the kidney. 4\. Comorbid infections (e.g. HIV, HBV, HCV) and serious illnesses. 5\. Cases in which partial nephrectomy is deemed appropriate. 6\. Cases other than those listed above, where the principal investigator performing the nephrectomy, the ethics review committee of the nephrectomy facility or the restorative renal transplantation review committee considers the case inappropriate as a subject. For Recipient: 1\.The patient has an active infection, bleeding ulcer or malignancy. 2\. The patient has a severe vascular or circulatory disorder (e.g. aortic aneurysm, cerebral thrombosis, myocardial infarction, thrombosis, pulmonary embolism), which may be exacerbated by transplantation. 3\. Patients other than those listed above who are deemed inappropriate for inclusion by the transplant facility's principal investigator, the transplant facility's ethical review committee or the restorative renal transplant review committee.